The following data is part of a premarket notification filed by Target Therapeutics with the FDA for Angioject.
Device ID | K860842 |
510k Number | K860842 |
Device Name: | ANGIOJECT |
Classification | Injector And Syringe, Angiographic |
Applicant | TARGET THERAPEUTICS 2100 SOUTH SEPULVEDA BLVD. Los Angeles, CA 90025 |
Contact | Marie Daniels |
Correspondent | Marie Daniels TARGET THERAPEUTICS 2100 SOUTH SEPULVEDA BLVD. Los Angeles, CA 90025 |
Product Code | DXT |
CFR Regulation Number | 870.1650 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1986-03-04 |
Decision Date | 1986-04-23 |